Celularity
CELU
33 hedge funds and large institutions have $93.8M invested in Celularity in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 33 closing their positions.
2,827% more call options, than puts
Call options by funds: $4.92M | Put options by funds: $168K
5% less ownership
Funds ownership: 8.21% → 3.21% (-5%)
48% less funds holding
Funds holding: 63 → 33 (-30)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
60% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 15
61% less capital invested
Capital invested by funds: $238M → $93.8M (-$144M)
88% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$14.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.53M |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$6.27M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.03M |
| 5 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$351K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$25.6M |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$17.6M |
| 3 |
SC
Shay Capital
New York
|
-$14.5M |
| 4 |
JP Morgan Chase
New York
|
-$11.7M |
| 5 |
Millennium Management
New York
|
-$9.88M |
CELU Hedge Fund Activity: Q2 2021 in Review
33 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q2 2021, worth a combined $93.8M — down 61% from $238M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of CELU and 4 opened new positions — a net loss of 29 holders — while 15 trimmed existing stakes and 6 added.
The largest buyer was Highbridge Capital Management, adding an estimated $14.6M. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $25.6M sold.
- 33 institutional investors held Celularity (CELU) as of Q2 2021, down from 63 in Q1 2021.
- Funds reported $93.8M of Celularity stock for Q2 2021, down 61% quarter-over-quarter.
- 4 funds opened new Celularity positions in Q2 2021 and 33 closed out, a net change of -29 holders.
- The largest Celularity buyer in Q2 2021 was Highbridge Capital Management, an estimated $14.6M added.
- The largest Celularity seller in Q2 2021 was Glazer Capital LLC, an estimated $25.6M sold.
Based on aggregated 13F filings for Q2 2021.